Growing cost of in vivo studies. Regulatory agency guidance. Increasing speed to market.
All of these are reasons modeling and simulation have become standard parts of drug discovery and development—but many organizations still have not realized the potential of mechanistic modeling and AI/machine learning tools. Why?
Education.
There simply aren’t enough scientists trained on the use of modeling and simulation methods. That’s why our experts have designed courses for both novice and experienced modelers to learn how to use different technologies and apply them to their research functions.